99 related articles for article (PubMed ID: 15932569)
21. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.
Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Wolff RA; Eng C; Krishnan S; Janjan NA; Crane CH
Cancer; 2007 May; 109(9):1750-5. PubMed ID: 17387743
[TBL] [Abstract][Full Text] [Related]
22. Squamous-cell carcinoma of the rectum: a rare but curable tumor.
Nahas CS; Shia J; Joseph R; Schrag D; Minsky BD; Weiser MR; Guillem JG; Paty PB; Klimstra DS; Tang LH; Wong WD; Temple LK
Dis Colon Rectum; 2007 Sep; 50(9):1393-400. PubMed ID: 17661147
[TBL] [Abstract][Full Text] [Related]
23. Multicentre prospective audit of surgical outcomes and acute complications following short course pre-operative radiotherapy for resectable rectal cancer.
Giridharan S; Vakkalanka B; Anwar MS; Geh JI; Glaholm J; Churn M; Adab F; Grieve R; McConkey C; Hartley A
Colorectal Dis; 2005 Jan; 7(1):43-6. PubMed ID: 15606583
[TBL] [Abstract][Full Text] [Related]
24. Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial.
Pietrzak L; Bujko K; Nowacki MP; Kepka L; Oledzki J; Rutkowski A; Szmeja J; Kladny J; Dymecki D; Wieczorek A; Pawlak M; Lesniak T; Kowalska T; Richter P;
Radiother Oncol; 2007 Sep; 84(3):217-25. PubMed ID: 17692977
[TBL] [Abstract][Full Text] [Related]
25. Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision.
Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Kepka L; Winkler-Spytkowska B; Suwiński R; Oledzki J; Stryczyńska G; Wieczorek A; Serkies K; Rogowska D; Tokar P;
Radiother Oncol; 2005 Sep; 76(3):234-40. PubMed ID: 16273666
[TBL] [Abstract][Full Text] [Related]
26. Post-operative concurrent chemoradiation therapy using oral uracil-tegafur versus weekly intravenous fluorouracil for locally advanced rectal cancer.
Hsieh CH; Chen YJ; Chang KH; Hsu HH; Liu CK; Hung SK; Chen HW; Lai YL; Hsu TC
Anticancer Res; 2006; 26(5B):3709-15. PubMed ID: 17094389
[TBL] [Abstract][Full Text] [Related]
27. Initial results of a randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery.
Latkauskas T; Pauzas H; Gineikiene I; Janciauskiene R; Juozaityte E; Saladzinskas Z; Tamelis A; Pavalkis D
Colorectal Dis; 2012 Mar; 14(3):294-8. PubMed ID: 21899712
[TBL] [Abstract][Full Text] [Related]
28. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.
Collette L; Bosset JF; den Dulk M; Nguyen F; Mineur L; Maingon P; Radosevic-Jelic L; Piérart M; Calais G;
J Clin Oncol; 2007 Oct; 25(28):4379-86. PubMed ID: 17906203
[TBL] [Abstract][Full Text] [Related]
29. Multimedia article. Laparoscopic abdominoanal pull-through procedure for male patients with lower rectal cancer after chemoradiation therapy.
Liang JT; Lai HS; Lee PH
Dis Colon Rectum; 2006 Feb; 49(2):259-60. PubMed ID: 16228818
[TBL] [Abstract][Full Text] [Related]
30. A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer.
Kundel Y; Brenner B; Symon Z; Oberman B; Sadezki S; Koller M; Catane R; Pfeffer R
Anticancer Res; 2007; 27(4C):2877-80. PubMed ID: 17695464
[TBL] [Abstract][Full Text] [Related]
31. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy of neoadjuvant radiochemotherapy in treatment of locally advanced low rectal cancer].
Yu BM; Zhang M; Wu WQ; Chen LW; Fu J; Fei CS; Shen Y
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):445-8. PubMed ID: 17686297
[TBL] [Abstract][Full Text] [Related]
33. Harm and benefits of short-term pre-operative radiotherapy in patients with resectable rectal carcinomas.
Bakx R; Emous M; Legemate DA; Zoetmulder FA; van Tienhoven G; Bemelman WA; van Lanschot JJ
Eur J Surg Oncol; 2006 Jun; 32(5):520-6. PubMed ID: 16600560
[TBL] [Abstract][Full Text] [Related]
34. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy.
Liang JT; Lai HS; Lee PH
Ann Surg Oncol; 2007 Apr; 14(4):1285-7. PubMed ID: 17235719
[TBL] [Abstract][Full Text] [Related]
35. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
[TBL] [Abstract][Full Text] [Related]
36. The impact of pre- or postoperative radiochemotherapy on complication following anterior resection with en bloc excision of female genitalia for T4 rectal cancer.
Szynglarewicz B; Matkowski R; Gisterek I; Forgacz J; Lacko A; Pudelko M; Kornafel J
Colorectal Dis; 2009 May; 11(4):377-81. PubMed ID: 18637920
[TBL] [Abstract][Full Text] [Related]
37. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.
Krempien R; Roeder F; Oertel S; Roebel M; Weitz J; Hensley FW; Timke C; Funk A; Bischof M; Zabel-Du Bois A; Niethammer AG; Eble MJ; Buchler MW; Treiber M; Debus J
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1143-51. PubMed ID: 16979835
[TBL] [Abstract][Full Text] [Related]
38. Preoperative chemoradiation followed by transanal excision for rectal cancer.
Huh JW; Jung EJ; Park YA; Lee KY; Sohn SK
J Surg Res; 2008 Aug; 148(2):244-50. PubMed ID: 17936793
[TBL] [Abstract][Full Text] [Related]
39. Chemo-radiotherapy versus radiotherapy alone in the pre-operative treatment of resectable rectal cancer.
Goethals L; Haustermans K; Perneel C; Bussels B; D'Hoore A; Geboes K; Ectors N; Van Cutsem E; Van den Bogaert W; Penninckx F
Eur J Surg Oncol; 2005 Nov; 31(9):969-76. PubMed ID: 15936170
[TBL] [Abstract][Full Text] [Related]
40. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
